NCT02188901View on ClinicalTrials.gov

Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study

NACompletedINTERVENTIONAL
Enrollment

523

Participants

Timeline

Start Date

October 15, 2014

Primary Completion Date

August 3, 2016

Study Completion Date

August 3, 2016

Conditions
Hepatocellular Carcinoma (HCC)
Interventions
OTHER

Sonazoid-enhanced ultrasonography

Sonazoid (perflubutane) \[GE healthcare\]

Trial Locations (1)

120-752

Severance Hospital, Yonsei University College of Medicine, Seoul

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

Yonsei University

OTHER